| Year |
Citation |
Score |
| 2018 |
Chao J, Guo Y, Chao L. Protective Role of Endogenous Kallistatin in Vascular Injury and Senescence by Inhibiting Oxidative Stress and Inflammation. Oxidative Medicine and Cellular Longevity. 2018: 4138560. PMID 30622668 DOI: 10.1155/2018/4138560 |
0.347 |
|
| 2018 |
Yao Y, Li B, Liu C, Fu C, Li P, Guo Y, Ma G, Liu N, Chao L, Chao J. Reduced Plasma Kallistatin Is Associated With the Severity of Coronary Artery Disease, and Kallistatin Treatment Attenuates Atherosclerotic Plaque Formation in Mice. Journal of the American Heart Association. 7: e009562. PMID 30554563 DOI: 10.1161/Jaha.118.009562 |
0.321 |
|
| 2017 |
Chao J, Guo Y, Li P, Chao L. Opposing Effects of Oxygen Regulation on Kallistatin Expression: Kallistatin as a Novel Mediator of Oxygen-Induced HIF-1-eNOS-NO Pathway. Oxidative Medicine and Cellular Longevity. 2017: 5262958. PMID 29387292 DOI: 10.1155/2017/5262958 |
0.325 |
|
| 2017 |
Guo Y, Li P, Gao L, Zhang J, Yang Z, Bledsoe G, Chang E, Chao L, Chao J. Kallistatin reduces vascular senescence and aging by regulating microRNA-34a-SIRT1 pathway. Aging Cell. PMID 28544111 DOI: 10.1111/Acel.12615 |
0.3 |
|
| 2016 |
Chao J, Bledsoe G, Chao L. Protective Role of Kallistatin in Vascular and Organ Injury. Hypertension. PMID 27432868 DOI: 10.1161/Hypertensionaha.116.07861 |
0.427 |
|
| 2015 |
Lin WC, Chen CW, Huang YW, Chao L, Chao J, Lin YS, Lin CF. Kallistatin protects against sepsis-related acute lung injury via inhibiting inflammation and apoptosis. Scientific Reports. 5: 12463. PMID 26198099 DOI: 10.1038/Srep12463 |
0.347 |
|
| 2014 |
Chao J, Bledsoe G, Chao L. Kallikrein-kinin in stem cell therapy. World Journal of Stem Cells. 6: 448-57. PMID 25258666 DOI: 10.4252/Wjsc.V6.I4.448 |
0.346 |
|
| 2014 |
Chao J, Bledsoe G, Chao L. Tissue kallikrein-kinin therapy in hypertension and organ damage. Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progrã¨S Des Recherches Pharmaceutiques. 69: 37-57. PMID 25130039 DOI: 10.1007/978-3-319-06683-7_3 |
0.39 |
|
| 2014 |
Li P, Bledsoe G, Yang ZR, Fan H, Chao L, Chao J. Human kallistatin administration reduces organ injury and improves survival in a mouse model of polymicrobial sepsis. Immunology. 142: 216-26. PMID 24467264 DOI: 10.1111/Imm.12242 |
0.392 |
|
| 2013 |
Yao Y, Sheng Z, Li Y, Fu C, Ma G, Liu N, Chao J, Chao L. Tissue kallikrein-modified human endothelial progenitor cell implantation improves cardiac function via enhanced activation of akt and increased angiogenesis. Laboratory Investigation; a Journal of Technical Methods and Pathology. 93: 577-91. PMID 23508045 DOI: 10.1038/Labinvest.2013.48 |
0.372 |
|
| 2012 |
Liu Y, Bledsoe G, Hagiwara M, Shen B, Chao L, Chao J. Depletion of endogenous kallistatin exacerbates renal and cardiovascular oxidative stress, inflammation, and organ remodeling. American Journal of Physiology. Renal Physiology. 303: F1230-8. PMID 22811485 DOI: 10.1152/Ajprenal.00257.2012 |
0.467 |
|
| 2012 |
Yao Y, Sheng Z, Li Y, Yan F, Fu C, Li Y, Ma G, Liu N, Chao J, Chao L. Tissue kallikrein promotes cardiac neovascularization by enhancing endothelial progenitor cell functional capacity. Human Gene Therapy. 23: 859-70. PMID 22435954 DOI: 10.1089/Hum.2011.123 |
0.449 |
|
| 2010 |
Shen B, Gao L, Hsu YT, Bledsoe G, Hagiwara M, Chao L, Chao J. Kallistatin attenuates endothelial apoptosis through inhibition of oxidative stress and activation of Akt-eNOS signaling. American Journal of Physiology. Heart and Circulatory Physiology. 299: H1419-27. PMID 20729399 DOI: 10.1152/Ajpheart.00591.2010 |
0.358 |
|
| 2010 |
Yin H, Gao L, Shen B, Chao L, Chao J. Kallistatin inhibits vascular inflammation by antagonizing tumor necrosis factor-alpha-induced nuclear factor kappaB activation. Hypertension. 56: 260-7. PMID 20566960 DOI: 10.1161/Hypertensionaha.110.152330 |
0.314 |
|
| 2010 |
Chao J, Shen B, Gao L, Xia CF, Bledsoe G, Chao L. Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing. Biological Chemistry. 391: 345-55. PMID 20180644 DOI: 10.1515/Bc.2010.042 |
0.42 |
|
| 2010 |
Liu Y, Bledsoe G, Hagiwara M, Yang ZR, Shen B, Chao L, Chao J. Blockade of endogenous tissue kallikrein aggravates renal injury by enhancing oxidative stress and inhibiting matrix degradation. American Journal of Physiology. Renal Physiology. 298: F1033-40. PMID 20089675 DOI: 10.1152/Ajprenal.00518.2009 |
0.45 |
|
| 2010 |
Shen B, Chao L, Chao J. Pivotal role of JNK-dependent FOXO1 activation in downregulation of kallistatin expression by oxidative stress. American Journal of Physiology. Heart and Circulatory Physiology. 298: H1048-54. PMID 20081110 DOI: 10.1152/Ajpheart.00826.2009 |
0.327 |
|
| 2010 |
Gao L, Chao L, Chao J. A novel signaling pathway of tissue kallikrein in promoting keratinocyte migration: activation of proteinase-activated receptor 1 and epidermal growth factor receptor. Experimental Cell Research. 316: 376-89. PMID 19879874 DOI: 10.1016/J.Yexcr.2009.10.022 |
0.309 |
|
| 2009 |
Hsieh JL, Shen PC, Shiau AL, Jou IM, Lee CH, Teo ML, Wang CR, Chao J, Chao L, Wu CL. Adenovirus-mediated kallistatin gene transfer ameliorates disease progression in a rat model of osteoarthritis induced by anterior cruciate ligament transection. Human Gene Therapy. 20: 147-58. PMID 20377366 DOI: 10.1089/Hum.2008.096 |
0.444 |
|
| 2009 |
Shen B, Smith RS, Hsu YT, Chao L, Chao J. Kruppel-like factor 4 is a novel mediator of Kallistatin in inhibiting endothelial inflammation via increased endothelial nitric-oxide synthase expression. The Journal of Biological Chemistry. 284: 35471-8. PMID 19858207 DOI: 10.1074/Jbc.M109.046813 |
0.312 |
|
| 2009 |
Smith RS, Gao L, Bledsoe G, Chao L, Chao J. Intermedin is a new angiogenic growth factor. American Journal of Physiology. Heart and Circulatory Physiology. 297: H1040-7. PMID 19592612 DOI: 10.1152/Ajpheart.00404.2009 |
0.453 |
|
| 2008 |
Hagiwara M, Bledsoe G, Yang ZR, Smith RS, Chao L, Chao J. Intermedin ameliorates vascular and renal injury by inhibition of oxidative stress. American Journal of Physiology. Renal Physiology. 295: F1735-43. PMID 18829738 DOI: 10.1152/Ajprenal.90427.2008 |
0.498 |
|
| 2008 |
Chao J, Yin H, Gao L, Hagiwara M, Shen B, Yang ZR, Chao L. Tissue kallikrein elicits cardioprotection by direct kinin b2 receptor activation independent of kinin formation. Hypertension. 52: 715-20. PMID 18768400 DOI: 10.1161/Hypertensionaha.108.114587 |
0.412 |
|
| 2008 |
Gao L, Yin H, S Smith R, Chao L, Chao J. Role of kallistatin in prevention of cardiac remodeling after chronic myocardial infarction. Laboratory Investigation; a Journal of Technical Methods and Pathology. 88: 1157-66. PMID 18762777 DOI: 10.1038/Labinvest.2008.85 |
0.422 |
|
| 2008 |
Yao YY, Yin H, Shen B, Smith RS, Liu Y, Gao L, Chao L, Chao J. Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3beta pathway. Cardiovascular Research. 80: 354-64. PMID 18689794 DOI: 10.1093/Cvr/Cvn223 |
0.375 |
|
| 2008 |
Smith RS, Gao L, Chao L, Chao J. Tissue kallikrein and kinin infusion promotes neovascularization in limb ischemia. Biological Chemistry. 389: 725-30. PMID 18627294 DOI: 10.1515/Bc.2008.084 |
0.464 |
|
| 2008 |
Hagiwara M, Shen B, Chao L, Chao J. Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation. Human Gene Therapy. 19: 807-19. PMID 18554097 DOI: 10.1089/Hum.2008.016 |
0.397 |
|
| 2008 |
Shen B, Hagiwara M, Yao YY, Chao L, Chao J. Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stress. Hypertension. 51: 1358-65. PMID 18391098 DOI: 10.1161/Hypertensionaha.107.108514 |
0.408 |
|
| 2008 |
Bledsoe G, Shen B, Yao YY, Hagiwara M, Mizell B, Teuton M, Grass D, Chao L, Chao J. Role of tissue kallikrein in prevention and recovery of gentamicin-induced renal injury. Toxicological Sciences : An Official Journal of the Society of Toxicology. 102: 433-43. PMID 18227104 DOI: 10.1093/Toxsci/Kfn008 |
0.429 |
|
| 2008 |
Yin H, Chao L, Chao J. Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion. Life Sciences. 82: 156-65. PMID 18068196 DOI: 10.1016/J.Lfs.2007.10.021 |
0.411 |
|
| 2007 |
Yao YY, Yin H, Shen B, Chao L, Chao J. Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarction. Journal of Cardiac Failure. 13: 588-96. PMID 17826650 DOI: 10.1016/J.Cardfail.2007.04.009 |
0.386 |
|
| 2007 |
Yin H, Chao J, Bader M, Chao L. Differential role of kinin B1 and B2 receptors in ischemia-induced apoptosis and ventricular remodeling. Peptides. 28: 1383-9. PMID 17644219 DOI: 10.1016/J.Peptides.2007.05.010 |
0.327 |
|
| 2007 |
Yuan G, Deng J, Wang T, Zhao C, Xu X, Wang P, Voltz JW, Edin ML, Xiao X, Chao L, Chao J, Zhang XA, Zeldin DC, Wang DW. Tissue kallikrein reverses insulin resistance and attenuates nephropathy in diabetic rats by activation of phosphatidylinositol 3-kinase/protein kinase B and adenosine 5'-monophosphate-activated protein kinase signaling pathways. Endocrinology. 148: 2016-26. PMID 17272402 DOI: 10.1210/En.2006-0602 |
0.366 |
|
| 2007 |
Chao J, Li HJ, Yao YY, Shen B, Gao L, Bledsoe G, Chao L. Kinin infusion prevents renal inflammation, apoptosis, and fibrosis via inhibition of oxidative stress and mitogen-activated protein kinase activity. Hypertension. 49: 490-7. PMID 17224475 DOI: 10.1161/01.Hyp.0000255925.01707.Eb |
0.418 |
|
| 2007 |
Yao YY, Yin H, Shen B, Chao L, Chao J. Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction. Regulatory Peptides. 140: 12-20. PMID 17196272 DOI: 10.1016/J.Regpep.2006.11.020 |
0.402 |
|
| 2007 |
Li HJ, Yin H, Yao YY, Shen B, Bader M, Chao L, Chao J. Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation. Cardiovascular Research. 73: 130-42. PMID 17137568 DOI: 10.1016/J.Cardiores.2006.10.014 |
0.33 |
|
| 2006 |
Chao J, Yin H, Yao YY, Shen B, Smith RS, Chao L. Novel role of kallistatin in protection against myocardial ischemia-reperfusion injury by preventing apoptosis and inflammation. Human Gene Therapy. 17: 1201-13. PMID 17081080 DOI: 10.1089/Hum.2006.17.1201 |
0.426 |
|
| 2006 |
Chao J, Bledsoe G, Yin H, Chao L. The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction. Biological Chemistry. 387: 665-75. PMID 16800727 DOI: 10.1515/Bc.2006.085 |
0.483 |
|
| 2006 |
Bledsoe G, Shen B, Yao Y, Zhang JJ, Chao L, Chao J. Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene delivery. Human Gene Therapy. 17: 545-55. PMID 16716111 DOI: 10.1089/Hum.2006.17.545 |
0.482 |
|
| 2006 |
Xia CF, Smith RS, Shen B, Yang ZR, Borlongan CV, Chao L, Chao J. Postischemic brain injury is exacerbated in mice lacking the kinin B2 receptor. Hypertension. 47: 752-61. PMID 16534002 DOI: 10.1161/01.Hyp.0000214867.35632.0E |
0.307 |
|
| 2006 |
Xia CF, Yin H, Yao YY, Borlongan CV, Chao L, Chao J. Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis. Human Gene Therapy. 17: 206-19. PMID 16454654 DOI: 10.1089/Hum.2006.17.206 |
0.404 |
|
| 2006 |
Bledsoe G, Crickman S, Mao J, Xia CF, Murakami H, Chao L, Chao J. Kallikrein/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosis. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 21: 624-33. PMID 16401625 DOI: 10.1093/Ndt/Gfi225 |
0.361 |
|
| 2006 |
Xia CF, Yin H, Borlongan CV, Chao J, Chao L. Postischemic infusion of adrenomedullin protects against ischemic stroke by inhibiting apoptosis and promoting angiogenesis. Experimental Neurology. 197: 521-30. PMID 16343485 DOI: 10.1016/J.Expneurol.2005.10.027 |
0.328 |
|
| 2005 |
Xia CF, Bledsoe G, Chao L, Chao J. Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats. American Journal of Physiology. Renal Physiology. 289: F622-31. PMID 15886273 DOI: 10.1152/Ajprenal.00427.2004 |
0.499 |
|
| 2005 |
Montanari D, Yin H, Dobrzynski E, Agata J, Yoshida H, Chao J, Chao L. Kallikrein gene delivery improves serum glucose and lipid profiles and cardiac function in streptozotocin-induced diabetic rats. Diabetes. 54: 1573-80. PMID 15855348 DOI: 10.2337/Diabetes.54.5.1573 |
0.771 |
|
| 2005 |
Wang CR, Chen SY, Wu CL, Liu MF, Jin YT, Chao L, Chao J. Prophylactic adenovirus-mediated human kallistatin gene therapy suppresses rat arthritis by inhibiting angiogenesis and inflammation. Arthritis and Rheumatism. 52: 1319-24. PMID 15818689 DOI: 10.1002/art.20991 |
0.368 |
|
| 2005 |
Smith RS, Agata J, Xia CF, Chao L, Chao J. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction. Life Sciences. 76: 2457-71. PMID 15763077 DOI: 10.1016/J.Lfs.2004.11.028 |
0.51 |
|
| 2005 |
Chao J, Chao L. Kallikrein-kinin in stroke, cardiovascular and renal disease. Experimental Physiology. 90: 291-8. PMID 15653716 DOI: 10.1113/expphysiol.2004.028464 |
0.38 |
|
| 2005 |
Yin H, Chao L, Chao J. Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways. The Journal of Biological Chemistry. 280: 8022-30. PMID 15611141 DOI: 10.1074/Jbc.M407179200 |
0.404 |
|
| 2004 |
Xia CF, Yin H, Borlongan CV, Chao J, Chao L. Adrenomedullin gene delivery protects against cerebral ischemic injury by promoting astrocyte migration and survival. Human Gene Therapy. 15: 1243-54. PMID 15684700 DOI: 10.1089/Hum.2004.15.1243 |
0.454 |
|
| 2004 |
Zhang JJ, Bledsoe G, Kato K, Chao L, Chao J. Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress. Kidney International. 66: 722-32. PMID 15253727 DOI: 10.1111/J.1523-1755.2004.00794.X |
0.426 |
|
| 2004 |
Chen LG, Wang ZR, Wan CM, Chao L, Chao J, Xing HY. Encapsulated transgene cells attenuate hypertension, cardiac hypertrophy and enhance renal function in Goldblatt hypertensive rats. The Journal of Gene Medicine. 6: 786-97. PMID 15241786 DOI: 10.1002/jgm.563 |
0.314 |
|
| 2004 |
Wang T, Li H, Zhao C, Chen C, Li J, Chao J, Chao L, Xiao X, Wang DW. Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries. Gene Therapy. 11: 1342-50. PMID 15175642 DOI: 10.1038/Sj.Gt.3302294 |
0.529 |
|
| 2004 |
Xia CF, Yin H, Borlongan CV, Chao L, Chao J. Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis. Hypertension. 43: 452-9. PMID 14698996 DOI: 10.1161/01.Hyp.0000110905.29389.E5 |
0.446 |
|
| 2004 |
Yin H, Chao L, Chao J. Adrenomedullin protects against myocardial apoptosis after ischemia/reperfusion through activation of Akt-GSK signaling. Hypertension. 43: 109-16. PMID 14662648 DOI: 10.1161/01.Hyp.0000103696.60047.55 |
0.391 |
|
| 2003 |
Zhao C, Wang P, Xiao X, Chao J, Chao L, Wang DW, Zeldin DC. Gene therapy with human tissue kallikrein reduces hypertension and hyperinsulinemia in fructose-induced hypertensive rats. Hypertension. 42: 1026-33. PMID 14568997 DOI: 10.1161/01.Hyp.0000097603.55404.35 |
0.499 |
|
| 2003 |
Bledsoe G, Chao L, Chao J. Kallikrein gene delivery attenuates cardiac remodeling and promotes neovascularization in spontaneously hypertensive rats. American Journal of Physiology. Heart and Circulatory Physiology. 285: H1479-88. PMID 12816755 DOI: 10.1152/Ajpheart.01129.2002 |
0.553 |
|
| 2003 |
Kato K, Yin H, Agata J, Yoshida H, Chao L, Chao J. Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion. American Journal of Physiology. Heart and Circulatory Physiology. 285: H1506-14. PMID 12805025 DOI: 10.1152/Ajpheart.00270.2003 |
0.453 |
|
| 2003 |
Agata J, Zhang JJ, Chao J, Chao L. Adrenomedullin gene delivery inhibits neointima formation in rat artery after balloon angioplasty. Regulatory Peptides. 112: 115-20. PMID 12667632 DOI: 10.1016/S0167-0115(03)00029-6 |
0.488 |
|
| 2003 |
Wang C, Chao J, Chao L. Adenovirus-mediated human prostasin gene delivery is linked to increased aldosterone production and hypertension in rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 284: R1031-6. PMID 12626364 DOI: 10.1152/Ajpregu.00660.2002 |
0.507 |
|
| 2003 |
Ni A, Yin H, Agata J, Yang Z, Chao L, Chao J. Overexpression of kinin B1 receptors induces hypertensive response to des-Arg9-bradykinin and susceptibility to inflammation. The Journal of Biological Chemistry. 278: 219-25. PMID 12411434 DOI: 10.1074/Jbc.M209490200 |
0.345 |
|
| 2002 |
Chao J, Chao L. The Role of Adrenomedullin in Cardiovascular and Renal Function. Drug News & Perspectives. 15: 511-518. PMID 12677190 |
0.412 |
|
| 2002 |
Dobrzynski E, Montanari D, Agata J, Zhu J, Chao J, Chao L. Adrenomedullin improves cardiac function and prevents renal damage in streptozotocin-induced diabetic rats. American Journal of Physiology. Endocrinology and Metabolism. 283: E1291-8. PMID 12424108 DOI: 10.1152/Ajpendo.00147.2002 |
0.782 |
|
| 2002 |
Agata J, Chao L, Chao J. Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction. Hypertension. 40: 653-9. PMID 12411458 DOI: 10.1161/01.Hyp.0000036035.41122.99 |
0.478 |
|
| 2002 |
Miao RQ, Agata J, Chao L, Chao J. Kallistatin is a new inhibitor of angiogenesis and tumor growth. Blood. 100: 3245-52. PMID 12384424 DOI: 10.1182/Blood-2002-01-0185 |
0.367 |
|
| 2002 |
Emanueli C, Salis MB, Pinna A, Stacca T, Milia AF, Spano A, Chao J, Chao L, Sciola L, Madeddu P. Prevention of diabetes-induced microangiopathy by human tissue kallikrein gene transfer. Circulation. 106: 993-9. PMID 12186806 DOI: 10.1161/01.Cir.0000027104.33206.C8 |
0.399 |
|
| 2002 |
Smith RS, Lin KF, Agata J, Chao L, Chao J. Human endothelial nitric oxide synthase gene delivery promotes angiogenesis in a rat model of hindlimb ischemia. Arteriosclerosis, Thrombosis, and Vascular Biology. 22: 1279-85. PMID 12171788 DOI: 10.1161/01.Atv.0000026613.18742.67 |
0.37 |
|
| 2002 |
Chao J, Wang C, Chao L. Adenovirus-mediated gene transfer for cardiovascular and renal diseases. Methods in Enzymology. 346: 247-63. PMID 11883071 DOI: 10.1016/S0076-6879(02)46059-4 |
0.374 |
|
| 2002 |
Yu H, Song Q, Freedman BI, Chao J, Chao L, Rich SS, Bowden DW. Association of the tissue kallikrein gene promoter with ESRD and hypertension. Kidney International. 61: 1030-9. PMID 11849458 DOI: 10.1046/J.1523-1755.2002.00198.X |
0.399 |
|
| 2002 |
Chao J, Chao L. The role of adrenomedullin in cardiovascular and renal function Drug News and Perspectives. 15: 511-518. DOI: 10.1358/dnp.2002.15.8.840072 |
0.415 |
|
| 2001 |
Chao J, Kato K, Zhang JJ, Dobrzynski E, Wang C, Agata J, Chao L. Human adrenomedullin gene delivery protects against cardiovascular remodeling and renal injury. Peptides. 22: 1731-7. PMID 11754958 DOI: 10.1016/S0196-9781(01)00510-1 |
0.823 |
|
| 2001 |
Emanueli C, Salis MB, Stacca T, Gaspa L, Chao J, Chao L, Piana A, Madeddu P. Rescue of Impaired Angiogenesis in Spontaneously Hypertensive Rats by Intramuscular Human Tissue Kallikrein Gene Transfer Hypertension. 38: 136-141. PMID 11463774 DOI: 10.1161/01.Hyp.38.1.136 |
0.489 |
|
| 2001 |
Wang C, Dobrzynski E, Chao J, Chao L. Adrenomedullin gene delivery attenuates renal damage and cardiac hypertrophy in Goldblatt hypertensive rats American Journal of Physiology-Renal Physiology. 280. PMID 11352835 DOI: 10.1152/Ajprenal.2001.280.6.F964 |
0.824 |
|
| 2001 |
Chao J, Miao RQ, Chen V, Chen LM, Chao L. Novel roles of kallistatin, a specific tissue kallikrein inhibitor, in vascular remodeling. Biological Chemistry. 382: 15-21. PMID 11258665 DOI: 10.1515/Bc.2001.003 |
0.394 |
|
| 2001 |
Emanueli C, Minasi A, Zacheo A, Chao J, Chao L, Salis MB, Straino S, Tozzi MG, Smith R, Gaspa L, Bianchini G, Stillo F, Capogrossi MC, Madeddu P. Local Delivery of Human Tissue Kallikrein Gene Accelerates Spontaneous Angiogenesis in Mouse Model of Hindlimb Ischemia Circulation. 103: 125-132. PMID 11136697 DOI: 10.1161/01.Cir.103.1.125 |
0.431 |
|
| 2000 |
Dobrzynski E, Wang C, Chao J, Chao L. Adrenomedullin gene delivery attenuates hypertension, cardiac remodeling, and renal injury in deoxycorticosterone acetate-salt hypertensive rats. Hypertension. 36: 995-1001. PMID 11116114 DOI: 10.1161/01.Hyp.36.6.995 |
0.819 |
|
| 2000 |
Emanueli C, Zacheo A, Minasi A, Chao J, Chao L, Salis MB, Stacca T, Straino S, Capogrossi MC, Madeddu PR. Adenovirus-Mediated Human Tissue Kallikrein Gene Delivery Induces Angiogenesis in Normoperfused Skeletal Muscle Arteriosclerosis, Thrombosis, and Vascular Biology. 20: 2379-2385. PMID 11073841 DOI: 10.1161/01.Atv.20.11.2379 |
0.405 |
|
| 2000 |
Silva JA, Araujo RC, Baltatu O, Oliveira SM, Tschöpe C, Fink E, Hoffmann S, Plehm R, Chai KX, Chao L, Chao J, Ganten D, Pesquero JB, Bader M. Reduced cardiac hypertrophy and altered blood pressure control in transgenic rats with the human tissue kallikrein gene. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 14: 1858-60. PMID 11023967 DOI: 10.1096/Fj.99-1010Fje |
0.518 |
|
| 2000 |
Agata J, Miao RQ, Yayama K, Chao L, Chao J. Bradykinin B(1) receptor mediates inhibition of neointima formation in rat artery after balloon angioplasty. Hypertension. 36: 364-70. PMID 10988266 DOI: 10.1161/01.Hyp.36.3.364 |
0.393 |
|
| 2000 |
Zhang JJ, Yoshida H, Chao L, Chao J. Human adrenomedullin gene delivery protects against cardiac hypertrophy, fibrosis, and renal damage in hypertensive dahl salt-sensitive rats. Human Gene Therapy. 11: 1817-27. PMID 10986555 DOI: 10.1161/01.Hyp.36.Suppl_1.691-A |
0.585 |
|
| 2000 |
Wolf WC, Yoshida H, Agata J, Chao L, Chao J. Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure. Kidney International. 58: 730-9. PMID 10916096 DOI: 10.1046/J.1523-1755.2000.00219.X |
0.447 |
|
| 2000 |
Emanueli C, Salis MB, Figueroa C, Chao J, Chao L, Gaspa L, Capogrossi MC, Madeddu P. Participation of kinins in the captopril-induced inhibition of intimal hyperplasia caused by interruption of carotid blood flow in the mouse. British Journal of Pharmacology. 130: 1076-1082. PMID 10882392 DOI: 10.1038/Sj.Bjp.0703388 |
0.353 |
|
| 2000 |
Chen VC, Chao L, Chao J. Reactive-site specificity of human kallistatin toward tissue kallikrein probed by site-directed mutagenesis. Biochimica Et Biophysica Acta. 1479: 237-246. PMID 10862973 DOI: 10.1016/S0167-4838(00)00044-3 |
0.306 |
|
| 2000 |
Emanueli C, Salis MB, Chao J, Chao L, Agata J, Lin KF, Munaò A, Straino S, Minasi A, Capogrossi MC, Madeddu P. Adenovirus-mediated human tissue kallikrein gene delivery inhibits neointima formation induced by interruption of blood flow in mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 20: 1459-66. PMID 10845858 DOI: 10.1161/01.Atv.20.6.1459 |
0.419 |
|
| 2000 |
Wang D, Yoshida H, Song Q, Chao L, Chao J. Enhanced renal function in bradykinin B2 receptor transgenic mice American Journal of Physiology-Renal Physiology. 278. PMID 10710553 DOI: 10.1152/Ajprenal.2000.278.3.F484 |
0.345 |
|
| 2000 |
Miao RQ, Murakami H, Song Q, Chao L, Chao J. Kallistatin stimulates vascular smooth muscle cell proliferation and migration in vitro and neointima formation in balloon-injured rat artery. Circulation Research. 86: 418-24. PMID 10700446 DOI: 10.1161/01.Res.86.4.418 |
0.368 |
|
| 2000 |
Yoshida H, Zhang JJ, Chao L, Chao J. Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischemia and reperfusion. Hypertension. 35: 25-31. PMID 10642270 DOI: 10.1161/01.Hyp.35.1.25 |
0.482 |
|
| 2000 |
Wang C, Montanari D, Chao L, Chao J. Adenovirus-Mediated Human Kallikrein Gene Delivery Increases Endogenous Rat Tissue Kallikrein in Hypertensive Rat Models Hypertension. 36: 729-729. DOI: 10.1161/01.Hyp.36.Suppl_1.729-C |
0.811 |
|
| 2000 |
Miao RQ, Agata J, Chao L, Chao J. Kallistatin Inhibits Endothelial Cell Proliferation, Migration and Adhesion in Vitro and Angiogenesis in the Ischemic Hindlimb of Rats Hypertension. 36: 706-707. DOI: 10.1161/01.Hyp.36.Suppl_1.706-E |
0.496 |
|
| 2000 |
Montanari D, Dobrzynski E, Chao J, Chao L. Human Tissue Kallikrein Gene Delivery Attenuates Cardiac Glycogen Accumulation in Streptozotocin-Induced Diabetic Rats Hypertension. 36: 703-703. DOI: 10.1161/01.Hyp.36.Suppl_1.703-C |
0.775 |
|
| 2000 |
Madeddu PR, Salis BM, Chao J, Chao L, Costanza E. Human Tissue Kallikrein Gene Transfer Induces Angiogenesis Hypertension. 36: 691-691. DOI: 10.1161/01.Hyp.36.Suppl_1.691-B |
0.386 |
|
| 2000 |
Emanueli C, Minasi A, Zacheo A, Chao J, Chao L, Salis BM, Madeddu PR, Capogrossi MC. Human Tissue Kallikrein Gene Transfer Accelerates Spontaneous Angiogenesis Response to Ischemia Hypertension. 36: 270-270. DOI: 10.1161/01.Hyp.36.Suppl_1.270-A |
0.429 |
|
| 1999 |
Chao J, Wang C, Chao L. Gene therapy for hypertension: a review of potential targets. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 11: 43-53. PMID 18031114 DOI: 10.2165/00063030-199911010-00005 |
0.403 |
|
| 1999 |
Murakami H, Miao RQ, Chao L, Chao J. Adenovirus-mediated kallikrein gene transfer inhibits neointima formation via increased production of nitric oxide in rat artery. Immunopharmacology. 44: 137-43. PMID 10604537 DOI: 10.1016/S0162-3109(99)00120-4 |
0.519 |
|
| 1999 |
Dobrzynski E, Yoshida H, Chao J, Chao L. Adenovirus-mediated kallikrein gene delivery attenuates hypertension and protects against renal injury in deoxycorticosterone-salt rats Immunopharmacology. 44: 57-65. PMID 10604525 DOI: 10.1016/S0162-3109(99)00121-6 |
0.822 |
|
| 1999 |
Madeddu P, Emanueli C, Gaspa L, Salis B, Milia AF, Chao L, Chao J. Role of the bradykinin B2 receptor in the maturation of blood pressure phenotype: lesson from transgenic and knockout mice. Immunopharmacology. 44: 9-13. PMID 10604518 DOI: 10.1016/S0162-3109(99)00105-8 |
0.361 |
|
| 1999 |
Zhang JJ, Wang C, Lin KF, Chao L, Chao J. Human tissue kallikrein attenuates hypertension and secretes into circulation and urine after intramuscular gene delivery in hypertensive rats. Clinical and Experimental Hypertension (New York, N.Y. : 1993). 21: 1145-60. PMID 10513833 DOI: 10.3109/10641969909052194 |
0.556 |
|
| 1999 |
Hatcher HC, Wright NM, Chao J, Chao L, Ma JX. Kallikrein-binding protein is induced by growth hormone in the dwarf rat. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 13: 1839-44. PMID 10506588 DOI: 10.1096/Fasebj.13.13.1839 |
0.456 |
|
| 1999 |
Zhang JJ, Chao L, Chao J. Adenovirus-mediated kallikrein gene delivery reduces aortic thickening and stroke-induced death rate in Dahl salt-sensitive rats. Stroke; a Journal of Cerebral Circulation. 30: 1925-31; discussion . PMID 10471446 DOI: 10.1161/01.Str.30.9.1925 |
0.463 |
|
| 1999 |
Murakami H, Yayama K, Miao RQ, Wang C, Chao L, Chao J. Kallikrein gene delivery inhibits vascular smooth muscle cell growth and neointima formation in the rat artery after balloon angioplasty. Hypertension. 34: 164-70. PMID 10454435 DOI: 10.1161/01.Hyp.34.2.164 |
0.542 |
|
| 1999 |
Murakami H, Yayama K, Chao J, Chao L. Atrial natriuretic peptide gene delivery attenuates gentamycin-induced nephrotoxicity in rats. Nephrology Dialysis Transplantation. 14: 1376-1384. PMID 10382996 DOI: 10.1093/Ndt/14.6.1376 |
0.556 |
|
| 1999 |
Emanueli C, Chao J, Regoli D, Chao L, Ni A, Madeddu P. The bradykinin B1 receptor and the central regulation of blood pressure in spontaneously hypertensive rats. British Journal of Pharmacology. 126: 1769-76. PMID 10372819 DOI: 10.1038/Sj.Bjp.0702527 |
0.357 |
|
| 1999 |
Jin L, Chao L, Chao J. Potassium supplement upregulates the expression of renal kallikrein and bradykinin B2 receptor in SHR American Journal of Physiology - Renal Physiology. 276. PMID 10070172 DOI: 10.1152/Ajprenal.1999.276.3.F476 |
0.454 |
|
| 1999 |
Lin KF, Chao J, Chao L. Atrial natriuretic peptide gene delivery reduces stroke-induced mortality rate in Dahl salt-sensitive rats. Hypertension. 33: 219-24. PMID 9931108 DOI: 10.1161/01.Hyp.33.1.219 |
0.515 |
|
| 1999 |
Wolf WC, Harley RA, Sluce D, Chao L, Chao J. Localization and expression of tissue kallikrein and kallistatin in human blood vessels. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 47: 221-8. PMID 9889257 DOI: 10.1177/002215549904700210 |
0.36 |
|
| 1998 |
Wolf WC, Harley RA, Sluce D, Chao L, Chao J. Cellular localization of kallistatin and tissue kallikrein in human pancreas and salivary glands. Histochemistry and Cell Biology. 110: 477-84. PMID 9826127 DOI: 10.1007/S004180050309 |
0.347 |
|
| 1998 |
Ni A, Chai KX, Chao L, Chao J. Molecular cloning and expression of rat bradykinin B1 receptor. Biochimica Et Biophysica Acta. 1442: 177-85. PMID 9804950 DOI: 10.1016/S0167-4781(98)00163-8 |
0.435 |
|
| 1998 |
Chao J, Zhang JJ, Lin KF, Chao L. Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats. Kidney International. 54: 1250-60. PMID 9767541 DOI: 10.1046/J.1523-1755.1998.00104.X |
0.495 |
|
| 1998 |
Lin KF, Chao J, Chao L. Atrial natriuretic peptide gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in salt-sensitive rats. Human Gene Therapy. 9: 1429-38. PMID 9681414 DOI: 10.1089/Hum.1998.9.10-1429 |
0.554 |
|
| 1998 |
Yayama K, Wang C, Chao L, Chao J. Kallikrein Gene Delivery Attenuates Hypertension and Cardiac Hypertrophy and Enhances Renal Function in Goldblatt Hypertensive Rats Hypertension. 31: 1104-1110. PMID 9576121 DOI: 10.1161/01.Hyp.31.5.1104 |
0.557 |
|
| 1998 |
Murakami H, Yayama K, Chao L, Chao J. Human kallikrein gene delivery protects against gentamycin-induced nephrotoxicity in rats Kidney International. 53: 1305-1313. PMID 9573546 DOI: 10.1046/J.1523-1755.1998.00867.X |
0.567 |
|
| 1998 |
Wang C, Chao C, Madeddu P, Chao L, Chao J. Central Delivery of Human Tissue Kallikrein Gene Reduces Blood Pressure in Hypertensive Rats Biochemical and Biophysical Research Communications. 244: 449-454. PMID 9514899 DOI: 10.1006/Bbrc.1998.8232 |
0.515 |
|
| 1998 |
Chao J, Zhang JJ, Lin KF, Chao L. Human kallikrein gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in Dahl salt-sensitive rats. Human Gene Therapy. 9: 21-31. PMID 9458239 DOI: 10.1089/Hum.1998.9.1-21 |
0.493 |
|
| 1998 |
Ni A, Chao L, Chao J. Transcription factor nuclear factor kappaB regulates the inducible expression of the human B1 receptor gene in inflammation. The Journal of Biological Chemistry. 273: 2784-91. PMID 9446586 DOI: 10.1074/Jbc.273.5.2784 |
0.329 |
|
| 1998 |
Yavama K, Okamoto H, Wang C, Chao L, Chao J. Adenovirus-Mediated Delivery of Human Tissue Kallikrein Gene Reduces Blood Pressure in Goldblatt-Hypertensive Rats Japanese Journal of Pharmacology. 76: 51. DOI: 10.1016/s0021-5198(19)40325-9 |
0.418 |
|
| 1997 |
Wang C, Ford P, Chao C, Chao L, Chao J. Effect of cyclosporin A on the expression of tissue kallikrein, kininogen, and bradykinin receptor in rat. American Journal of Physiology. Renal Physiology. 273: F783-F789. PMID 29587107 DOI: 10.1152/Ajprenal.1997.273.5.F783 |
0.455 |
|
| 1997 |
Chao J, Jin L, Lin KF, Chao L. Adrenomedullin gene delivery reduces blood pressure in spontaneously hypertensive rats. Hypertension Research : Official Journal of the Japanese Society of Hypertension. 20: 269-77. PMID 9453262 DOI: 10.1291/Hypres.20.269 |
0.477 |
|
| 1997 |
Richards GP, Chao L, Chao J. Distribution of tissue kallikreins in lower vertebrates: potential physiological roles for fish kallikreins. Comparative Biochemistry and Physiology. Part C, Pharmacology, Toxicology & Endocrinology. 118: 49-58. PMID 9366035 DOI: 10.1016/S0742-8413(97)00031-5 |
0.317 |
|
| 1997 |
Richards GP, Liang YM, Chao J, Chao L. Purification, characterization and activation of fish muscle prokallikrein. Comparative Biochemistry and Physiology. Part C, Pharmacology, Toxicology & Endocrinology. 118: 39-48. PMID 9366034 DOI: 10.1016/S0742-8413(97)00030-3 |
0.301 |
|
| 1997 |
Jin L, Zhang JJ, Chao L, Chao J. Gene therapy in hypertension: adenovirus-mediated kallikrein gene delivery in hypertensive rats. Human Gene Therapy. 8: 1753-61. PMID 9358025 DOI: 10.1089/Hum.1997.8.15-1753 |
0.568 |
|
| 1997 |
Chao J, Chao L. Experimental kallikrein gene therapy in hypertension, cardiovascular and renal diseases Pharmacological Research. 35: 517-522. PMID 9356201 DOI: 10.1006/phrs.1997.0179 |
0.467 |
|
| 1997 |
Chai KX, Chen VC, Ni A, Lindpaintner K, Rubattu S, Chao L, Chao J. Molecular cloning and expression of rat kallistatin gene. Biochimica Et Biophysica Acta. 1353: 277-86. PMID 9349723 DOI: 10.1016/S0167-4781(97)00100-0 |
0.402 |
|
| 1997 |
Lin KF, Chao L, Chao J. Prolonged reduction of high blood pressure with human nitric oxide synthase gene delivery. Hypertension. 30: 307-13. PMID 9314409 DOI: 10.1161/01.Hyp.30.3.307 |
0.467 |
|
| 1997 |
Chao J, Yang Z, Jin L, Lin KF, Chao L. Kallikrein gene therapy in newborn and adult hypertensive rats. Canadian Journal of Physiology and Pharmacology. 75: 750-6. PMID 9276159 DOI: 10.1139/Y97-086 |
0.44 |
|
| 1997 |
Chao J, Chao L. Kallikrein gene therapy: A new strategy for hypertensive diseases Immunopharmacology. 36: 229-236. PMID 9228551 DOI: 10.1016/S0162-3109(97)00026-X |
0.444 |
|
| 1997 |
Wang C, Chao C, Chao L, Chao J. Expression of human tissue kallikrein in rat salivary glands and its secretion into circulation following adenovirus-mediated gene transfer Immunopharmacology. 36: 221-227. PMID 9228550 DOI: 10.1016/S0162-3109(97)00025-8 |
0.504 |
|
| 1997 |
Xiong W, Wang J, Chao L, Chao J. Tissue-specific expression and promoter analyses of the human tissue kallikrein gene in transgenic mice. The Biochemical Journal. 111-6. PMID 9224635 DOI: 10.1042/Bj3250111 |
0.371 |
|
| 1997 |
Chao J, Stallone JN, Liang YM, Chen LM, Wang DZ, Chao L. Kallistatin is a potent new vasodilator. The Journal of Clinical Investigation. 100: 11-7. PMID 9202051 DOI: 10.1172/JCI119502 |
0.335 |
|
| 1997 |
Xiong W, Chao J, Chao L. Expression and localization of human kallistatin in rat submandibular gland after intracapsular gene injection. Biochemical and Biophysical Research Communications. 231: 494-498. PMID 9070307 DOI: 10.1006/Bbrc.1996.5946 |
0.513 |
|
| 1997 |
Chen LM, Chao L, Chao J. Adenovirus-mediated delivery of human kallistatin gene reduces blood pressure of spontaneously hypertensive rats Human Gene Therapy. 8: 341-347. PMID 9048201 DOI: 10.1089/HUM.1997.8.3-341 |
0.464 |
|
| 1997 |
Wang D, Chao L, Chao J. Hypotension in Transgenic Mice Overexpressing Human Bradykinin B2 Receptor Hypertension. 29: 488-493. PMID 9039147 DOI: 10.1161/01.Hyp.29.1.488 |
0.368 |
|
| 1997 |
Ma JX, Song Q, Hatcher HC, Crouch RK, Chao L, Chao J. Expression and cellular localization of the kallikrein-kinin system in human ocular tissues. Experimental Eye Research. 63: 19-26. PMID 8983960 DOI: 10.1006/Exer.1996.0087 |
0.374 |
|
| 1997 |
Chao J, Chai KX, Chao L. Tissue kallikrein inhibitors in mammals. Immunopharmacology. 32: 67-72. PMID 8796269 DOI: 10.1016/0162-3109(96)00010-0 |
0.398 |
|
| 1997 |
Chao J, Chao L. Kallistatin in blood pressure regulation: Transgenic and somatic gene delivery studies Trends in Cardiovascular Medicine. 7: 307-311. DOI: 10.1016/S1050-1738(97)00089-3 |
0.367 |
|
| 1996 |
Madeddu P, Parpaglia PP, Glorioso N, Chao L, Chao J. Antisense Inhibition of the Brain Kallikrein-Kinin System Hypertension. 28: 980-987. PMID 8952586 DOI: 10.1161/01.Hyp.28.6.980 |
0.408 |
|
| 1996 |
Song Q, Chao J, Chao L. High level of circulating human tissue kallikrein induces hypotension in a transgenic mouse model Clinical and Experimental Hypertension. 18: 975-993. PMID 8922341 DOI: 10.3109/10641969609081030 |
0.4 |
|
| 1996 |
Chen LM, Ma JX, Liang YM, Chao L, Chao J. Tissue Kallikrein-binding Protein Reduces Blood Pressure in Transgenic Mice Journal of Biological Chemistry. 271: 27590-27594. PMID 8910346 DOI: 10.1074/Jbc.271.44.27590 |
0.373 |
|
| 1996 |
Wang C, Chao C, Chen LM, Chao L, Chao J. High-salt diet upregulates kininogen and downregulates tissue kallikrein expression in Dahl-SS and SHR rats American Journal of Physiology-Renal Physiology. 271. PMID 8898012 DOI: 10.1152/Ajprenal.1996.271.4.F824 |
0.45 |
|
| 1996 |
Wang DZ, Chao L, Chao J. Cellular localization of bradykinin B1 receptor mRNA in the human kidney Immunopharmacology. 33: 151-156. PMID 8856137 DOI: 10.1016/0162-3109(96)00011-2 |
0.311 |
|
| 1996 |
Wang DZ, Song Q, Chen LM, Chao L, Chao J. Expression and cellular localization of tissue kallikrein-kinin system in human adrenal gland. American Journal of Physiology-Renal Physiology. 271. PMID 8853434 DOI: 10.1152/Ajprenal.1996.271.3.F709 |
0.365 |
|
| 1996 |
Yu JX, Chao L, Ward DC, Chao J. Structure and chromosomal localization of the human prostasin (PRSS8) gene. Genomics. 32: 334-40. PMID 8838796 DOI: 10.1006/Geno.1996.0127 |
0.331 |
|
| 1996 |
Chai KX, Ni A, Wang D, Ward DC, Chao J, Chao L. Genomic DNA sequence, expression, and chromosomal localization of the human B1 bradykinin receptor gene BDKRB1. Genomics. 31: 51-7. PMID 8808279 DOI: 10.1006/Geno.1996.0008 |
0.36 |
|
| 1996 |
Song Q, Chao J, Chao L. High level expression of human tissue kallikrein in the circulation induces hypotension in transgenic mice Immunopharmacology. 32: 105-107. PMID 8796281 DOI: 10.1016/0162-3109(95)00065-8 |
0.401 |
|
| 1996 |
Richards GP, Chao J, Chao L. Tissue kallikreins in evolutionarily diverse vertebrates. Immunopharmacology. 32: 94-5. PMID 8796277 DOI: 10.1016/0162-3109(95)00061-5 |
0.35 |
|
| 1996 |
Chao C, Madeddu P, Wang C, Liang Y, Chao L, Chao J. Differential regulation of kallikrein, kininogen, and kallikrein-binding protein in arterial hypertensive rats American Journal of Physiology-Renal Physiology. 271. PMID 8760246 DOI: 10.1152/Ajprenal.1996.271.1.F78 |
0.423 |
|
| 1996 |
Chao J, Jin L, Chen L, Chen VC, Chao L. Systemic and portal vein delivery of human kallikrein gene reduces blood pressure in hypertensive rats. Human Gene Therapy. 7: 901-911. PMID 8727504 DOI: 10.1089/Hum.1996.7.8-901 |
0.469 |
|
| 1996 |
Ma JX, Chao J, Chao L. Identification and characterization of two promoters of rat kallikrein-binding protein gene Biochimica Et Biophysica Acta. 1307: 285-293. PMID 8688463 DOI: 10.1016/0167-4781(96)81374-1 |
0.408 |
|
| 1996 |
Chao J, Schmaier AH, Chen LM, Yang Z, Chao L. Kallistatin, a novel human tissue kallikrein inhibitor: levels in body fluids, blood cells, and tissues in health and disease. Journal of Laboratory and Clinical Medicine. 127: 612-620. PMID 8648266 DOI: 10.1016/S0022-2143(96)90152-3 |
0.348 |
|
| 1996 |
Chao J, Chao L. Functional analysis of human tissue kallikrein in transgenic mouse models Hypertension. 27: 491-494. PMID 8613191 DOI: 10.1161/01.Hyp.27.3.491 |
0.442 |
|
| 1996 |
Wang C, Chen YP, Chao L, Chao J. Regulatory elements in the promoter region of the renal kallikrein gene in normotensive vs hypertensive rats. Biochemical and Biophysical Research Communications. 217: 113-22. PMID 8526898 DOI: 10.1006/BBRC.1995.2752 |
0.38 |
|
| 1995 |
Ma JX, Wang DZ, Ward DC, Chen L, Dessai T, Chao J, Chao L. Structure and chromosomal localization of the gene (BDKRB2) encoding human bradykinin B2 receptor. Genomics. 23: 362-9. PMID 7835885 DOI: 10.1006/Geno.1994.1512 |
0.374 |
|
| 1995 |
Ma J, Yang Z, Chao J, Chao L. Intramuscular delivery of rat kallikrein-binding protein gene reverses hypotension in transgenic mice expressing human tissue kallikrein. Journal of Biological Chemistry. 270: 451-455. PMID 7814410 DOI: 10.1074/Jbc.270.1.451 |
0.414 |
|
| 1995 |
Chen LM, Richards GP, Chao L, Chao J. Molecular cloning, purification and in situ localization of human colon kallikrein. The Biochemical Journal. 307: 481-6. PMID 7733886 DOI: 10.1042/Bj3070481 |
0.371 |
|
| 1995 |
Xiong W, Chao J, Chao L. Muscle delivery of human kallikrein gene reduces blood pressure in hypertensive rats Hypertension. 25: 715-719. PMID 7721421 DOI: 10.1161/01.Hyp.25.4.715 |
0.521 |
|
| 1995 |
Wang C, Chao L, Chao J. Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats Journal of Clinical Investigation. 95: 1710-1716. PMID 7535795 DOI: 10.1172/Jci117847 |
0.532 |
|
| 1995 |
Lin KF, Chao J, Chao L. Human atrial natriuretic peptide gene delivery reduces blood pressure in hypertensive rats. Hypertension. 26: 847-53. PMID 7490138 DOI: 10.1161/01.Hyp.26.6.847 |
0.496 |
|
| 1995 |
Chen LM, Song Q, Chao L, Chao J. Cellular localization of tissue kallikrein and kallistatin mRNAs in human kidney Kidney International. 48: 690-697. PMID 7474653 DOI: 10.1038/Ki.1995.339 |
0.391 |
|
| 1995 |
Madeddu P, Chao J, Chao L, Soregaroli M, Valcamonico A, Valsecchi L, Glorioso N, Frusca T. Urinary Levels of Kallikrein and Kallistatin in Pregnancy-Induced Hypertension Hypertension in Pregnancy. 14: 201-212. DOI: 10.3109/10641959509009581 |
0.305 |
|
| 1994 |
Wang Dz, Ma Jx, Chao L, Chao J. Molecular cloning and sequence analysis of rat bradykinin B2 receptor gene. Biochimica Et Biophysica Acta. 1219: 171-174. PMID 8086459 DOI: 10.1016/0167-4781(94)90264-X |
0.387 |
|
| 1994 |
Wang J, Xiong W, Yang Z, Davis T, Dewey MJ, Chao J, Chao L. Human tissue kallikrein induces hypotension in transgenic mice. Hypertension. 23: 236-43. PMID 7508423 DOI: 10.1161/01.Hyp.23.2.236 |
0.379 |
|
| 1993 |
Chao J, Simson JAV, Chung P, Chen L, Chao L. Regulation of Kininogen Gene Expression and Localization in the Lung after Monocrotaline-Induced Pulmonary Hypertension in Rats Experimental Biology and Medicine. 203: 243-250. PMID 8502664 DOI: 10.3181/00379727-203-43597 |
0.439 |
|
| 1993 |
Ma J, Chao L, Zhou G, Chao J. Expression and characterization of rat kallikrein-binding protein in Escherichia coli. Biochemical Journal. 292: 825-832. PMID 8318011 DOI: 10.1042/Bj2920825 |
0.388 |
|
| 1993 |
Lin F, Lin C, Chou CC, Chen K, Lu HS, Bacheller W, Herrera C, Jones T, Chao J, Chao L. Molecular cloning and sequence analysis of the monkey and human tissue kallikrein genes Biochimica Et Biophysica Acta. 1173: 325-328. PMID 7916636 DOI: 10.1016/0167-4781(93)90131-V |
0.439 |
|
| 1992 |
Chai KX, Chao J, Chao L. Molecular cloning and sequence analysis of the mouse kallikrein-binding protein gene. Biochimica Et Biophysica Acta. 1129: 127-30. PMID 1756173 DOI: 10.1016/0167-4781(91)90227-D |
0.354 |
|
| 1992 |
Chen L, Chung P, Chao S, Chao L, Chao J. Differential regulation of kininogen gene expression by estrogen and progesterone in vivo. Biochimica Et Biophysica Acta. 1131: 145-151. PMID 1610894 DOI: 10.1016/0167-4781(92)90069-C |
0.487 |
|
| 1992 |
Jaffa AA, Chai KX, Chao J, Chao L, Mayfield RK. Effects of diabetes and insulin on expression of kallikrein and renin genes in the kidney. Kidney International. 41: 789-95. PMID 1513101 DOI: 10.1038/Ki.1992.122 |
0.442 |
|
| 1992 |
Ma JX, Chao J, Chao L. Molecular cloning and characterization of rKlk10, a cDNA encoding T-kininogenase from rat submandibular gland and kidney. Biochemistry. 31: 10922-10928. PMID 1420203 DOI: 10.1021/Bi00159A036 |
0.334 |
|
| 1990 |
Chao S, Chai KX, Chao L, Chao J. Molecular cloning and primary structure of rat α1-antitrypsin Biochemistry. 29: 323-329. PMID 2302382 DOI: 10.1021/Bi00454A004 |
0.36 |
|
| 1989 |
Chen YP, Chao J, Chao L. Molecular cloning and characterization of two rat renal kallikrein genes. Biochemistry. 27: 7189-96. PMID 2849988 DOI: 10.1021/BI00419A005 |
0.305 |
|
| 1989 |
Xiong W, Chao L, Chao J. Renal kallikrein mRNA localization by in situ hybridization Kidney International. 35: 1324-1329. PMID 2770112 DOI: 10.1038/Ki.1989.130 |
0.438 |
|
| 1989 |
Woodley-Miller C, Chao J, Chao L. Restriction fragment length polymorphisms mapped in spontaneously hypertensive rats using kallikrein probes. Journal of Hypertension. 7: 865-871. PMID 2575114 DOI: 10.1097/00004872-198911000-00003 |
0.405 |
|
| 1989 |
Shai SY, Woodley-Miller C, Chao J, Chao L. Characterization of genes encoding rat tonin and a kallikrein-like serine protease. Biochemistry. 28: 5334-5343. PMID 2550051 DOI: 10.1021/Bi00439A005 |
0.443 |
|
| 1989 |
Chao L, Chen Y, Woodley-Miller C, Li L, Harten Kv, Chao J. Structural Analysis of a Rat Renal Kallikrein Gene Advances in Experimental Medicine and Biology. 73-80. PMID 2481394 DOI: 10.1007/978-1-4615-9543-4_11 |
0.456 |
|
| 1988 |
Simson JAV, Condon JL, Chao L, Chao J. Comparison of the distribution of tissue kallikrein and esterase A, a kallikrein-like enzyme, in rat kidney using specific monoclonal antibodies. Journal of Histochemistry and Cytochemistry. 36: 1251-1254. PMID 3418106 DOI: 10.1177/36.10.3418106 |
0.363 |
|
| 1988 |
Chao J, Mayfield RK, Chao L. Circulating Autoantibodies to Mammalian Tissue Kallikreins Proceedings of the Society For Experimental Biology and Medicine. 187: 320-326. PMID 3347609 DOI: 10.3181/00379727-187-42671 |
0.311 |
|
| 1988 |
Simson JAV, Condon J, Fenters R, Chao L, Chao J. Immunocytochemical localization of a kallikrein‐like serin protease (Esterase A) in rat salivary glands Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology. 221: 475-481. PMID 3291641 DOI: 10.1002/Ar.1092210104 |
0.313 |
|
| 1988 |
Chao J, Swain C, Chao S, Xiong W, Chao L. Tissue distribution and kininogen gene expression after acute-phase inflammation Biochimica Et Biophysica Acta. 964: 329-339. PMID 3126819 DOI: 10.1016/0304-4165(88)90033-5 |
0.386 |
|
| 1987 |
Chao J, Chao L, Swain CC, Tsai J, Margolius HS. Tissue kallikrein in rat brain and pituitary: regional distribution and estrogen induction in the anterior pituitary. Endocrinology. 120: 475-482. PMID 3643103 DOI: 10.1210/Endo-120-2-475 |
0.355 |
|
| 1987 |
Shimojo N, Chao J, Chao L, Margolius HS, Mayfield RK. Identification and characterization of a tissue kallikrein in rat skeletal muscles. Biochemical Journal. 243: 773-778. PMID 3311022 DOI: 10.1042/Bj2430773 |
0.324 |
|
| 1987 |
Woodley-Miller C, Chao J, Chao L. Identification of tonin in brain and exocrine tissues and in the cell-free translation products encoded by the mRNA of these tissues. Biochemical Journal. 248: 477-481. PMID 2829829 DOI: 10.1042/Bj2480477 |
0.333 |
|
| 1986 |
Chao J, Tillman DM, Wang MY, Margolius HS, Chao L. Identification of a new tissue-kallikrein-binding protein. The Biochemical Journal. 239: 325-31. PMID 3643793 DOI: 10.1042/Bj2390325 |
0.302 |
|
| 1986 |
Chao L, Gerald W, Chao J. Characterization of rat kallikrein-like multigene family and its expression in the submandibular gland Advances in Experimental Medicine and Biology. 198: 189-194. PMID 3643703 DOI: 10.1007/978-1-4684-5143-6_26 |
0.433 |
|
| 1986 |
Gerald WL, Chao J, Chao L. Sex dimorphism and hormonal regulation of rat tissue kallikrein mRNA Bba - Gene Structure and Expression. 867: 16-23. PMID 3635414 DOI: 10.1016/0167-4781(86)90024-2 |
0.353 |
|
| 1986 |
Gerald WL, Chao J, Chao L. Immunological identification of rat tissue kallikrein cDNA and characterization of the kallikrein gene family Bba - Gene Structure and Expression. 866: 1-14. PMID 3004582 DOI: 10.1016/0167-4781(86)90093-X |
0.43 |
|
| 1986 |
Chao J, Chao L, Woodley CM, Gerald W, Margolius HS. Active Kallikrein, Preprokallikrein, and Kallikrein-Inhibitor Complex Advances in Experimental Medicine and Biology. 181-7. PMID 2880478 DOI: 10.1007/978-1-4684-5143-6_25 |
0.381 |
|
| 1985 |
Woodley CM, Chao J, Margolius HS, Chao L. Specific identification of tissue kallikrein in exocrine tissues and in cell-free translation products with monoclonal antibodies. Biochemical Journal. 231: 721-728. PMID 3907624 DOI: 10.1042/Bj2310721 |
0.3 |
|
| 1985 |
Simson JAV, Dom R, Chao J, Woodley C, Chao L, Margolius HS. Immunocytochemical localization of tissue kallikrein in brain ventricular epithelium and hypothalamic cell bodies Journal of Histochemistry and Cytochemistry. 33: 951-953. PMID 3894505 DOI: 10.1177/33.9.3894505 |
0.366 |
|
| 1984 |
Chao J, Chao L, Margolius HS. Isolation of tissue kallikrein in rat spleen by monoclonal antibody-affinity chromatography Bba - General Subjects. 801: 244-249. PMID 6566577 DOI: 10.1016/0304-4165(84)90073-4 |
0.383 |
|
| Show low-probability matches. |